alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › access

access

3 studies tagged access, dated 2016-02-04 to 2023-06-06. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Preparedness of China's health care system to provide access to a disease-modifying Alzheimer's treatment 2023-06-06
  2. Preparedness of the Brazilian health-care system to provide access to a disease-modifying Alzheimer's disease treatment 2022-09-05
  3. The dynamic mechanism of presenilin-1 function: Sensitive gate dynamics and loop unplugging control protein access 2016-02-04

Studies

3 studies carry this tag.

Date range

2016 to 2023

Top journals

  • Alzheimer's & dementia : the journal of the Alzheimer's Association 2
  • Neurobiology of disease 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Preparedness of China's health care system to provide access to a disease-modifying Alzheimer's treatment

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2023-06-06 Biomarkers

    Closing this gap will require the introduction of high-performing blood tests, greater reliance on cerebrospinal fluid (CSF) testing, and expansion of positron emission tomography (PET) capacity.

  2. Preparedness of the Brazilian health-care system to provide access to a disease-modifying Alzheimer's disease treatment

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2022-09-05 Biomarkers

    Brazil has no national dementia strategy or established pathway for evaluation of cognitive concerns, and dementia is typically diagnosed late if at all.

  3. The dynamic mechanism of presenilin-1 function: Sensitive gate dynamics and loop unplugging control protein access

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Neurobiology of disease 2016-02-04 Biomarkers

    There is no molecular explanation for the many presenilin 1 (PSEN1) mutations causing Alzheimer's disease, but both gain of function relating to amyloid production and loss of isolated PSEN1 function have been implied.

All topic tags with their study counts